Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Valinomycin
Cat. No.:
OB0225LY-0320
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Valinomycin is a cyclic lactone antibiotic mainly used to study cell membranes and ion permeability.
Synonym:
NSC 122023; 2001-95-8; Potassium ionophore I; Cyclo[-D-O-Val-D-Val-L-O-Ala-L-Val]3; Cyclic(D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl)
CAS No.:
2001-95-8
Compound CID:
3000706
Formula:
C54H90N6O18
Formula Weight:
1111.32
Specification
Relative Density:
1.06 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Valinomycin can be used in membrane biology studies or play an important role in studying the role of ion channels and electron transport.
Library Information
Targets:
Kinases
Receptors:
PTEN-induced kinase 1 (PINK1)
Pathways:
Microbiology/Virology; Apoptosis; Autophagy; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-5
Plate Location:
b4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
20 mg/mL; 18 mM
Ethanol Max Solubility:
40 mg/mL; 36 mM
